Cart
sales@molnova.com
Necroptosis-IN-3
CAS No. 547698-18-0
Necroptosis-IN-3( —— )
Catalog No. M35795 CAS No. 547698-18-0
Necroptosis-IN-3 (Cyclohexanecarboxamide, N-(2-thienylmethyl)-) (Compound 69) is a Necroptosis inhibitor that inhibits TNF-α induced necroptosis. Necroptosis-IN-3 (Compound STX1638) also inhibits 11β-HSD1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 55 | In Stock |
|
| 10MG | 98 | In Stock |
|
| 25MG | 191 | In Stock |
|
| 50MG | 297 | In Stock |
|
| 100MG | 420 | In Stock |
|
| 200MG | 583 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNecroptosis-IN-3
-
NoteResearch use only, not for human use.
-
Brief DescriptionNecroptosis-IN-3 (Cyclohexanecarboxamide, N-(2-thienylmethyl)-) (Compound 69) is a Necroptosis inhibitor that inhibits TNF-α induced necroptosis. Necroptosis-IN-3 (Compound STX1638) also inhibits 11β-HSD1.
-
DescriptionNecroptosis-IN-3 (Compound 69) is a necroptosis inhibitor that inhibits TNF-α induced necroptosis. Necroptosis-IN-3 (Compound STX1638) also inhibits 11β-HSD1.
-
In VitroCell Viability Assay Cell Line:Fadd-/- Jurkat and L929 cells, treated with 10 ng/mL of human TNF-α Concentration:0.030-100 μM Incubation Time:24 h Result:Showed necroptosis inhibitory activity with an ED50 of 7.724 μM for Fadd-/- Jurkat cells and was inactive for L929 cells.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorNecroptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number547698-18-0
-
Formula Weight223.33
-
Molecular FormulaC12H17NOS
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (447.77 mM; Ultrasonic )
-
SMILESC(NCC1=CC=CS1)(=O)C2CCCCC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Junying Yuan, et al. Small molecule inhibitors of necroptosis. Patent US20120122889A1.
molnova catalog
related products
-
BT18
BT18 is a mimic with function similar to glial cell line-derived neurotrophic factor (GDNF).
-
Rhamnetin 3-galactos...
Rhamnetin 3-galactoside is a natural product for research related to life sciences.
-
Remimazolam
Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?
